Mars Partners with Pairwise to Accelerate Cacao Research Using CRISPR platform
On Aug. 6, Mars has licensed Pairwise’s Fulcrum® gene editing tools for cacao research and development. This licensing…
On Aug. 6, Mars has licensed Pairwise’s Fulcrum® gene editing tools for cacao research and development. This licensing…
On Jul. 24, 2025, The China Times reported that China is making inroads in the race for innovative…
On Jul. 24, 2025, researchers at the Broad Institute and the National Emerging Infectious Diseases Laboratories (NEIDL) at…
On Jul. 8, 2025, Colossal Biosciences announced the moa as its next de-extinction focus, continuing its mission to…
On Jul. 8, 2025, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) announced the funding of the…
On Jul. 7, 2025, Australian scientists, including at the Charles Perkins Centre, University of Sydney, have successfully developed…
On Jun. 30, 2025, as in something out of science fiction, a team of researchers reached into the…
On May 15, 2025, a team at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine announced that a…
On May 4, 2025, Union Agriculture and Farmers Welfare Minister Shri Shivraj Singh Chouhan announced that two genome-edited…
On Apr. 7, 2025, scientists at Colossal Biosciences announced the successful de-extinction of the dire wolf with the…
On April 3, France’s Université Paris-Saclay said it is one of dozens of European institutions ramping up efforts…
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
On Mar. 4, 2025, Colossal Biosciences announced that its scientists have simultaneously edited seven genes in mice embryos…
On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…
On Dec. 2, 2024, engineers in the University of Southern Califoronia (USC) Alfred E. Mann Department of Biomedical…
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
On Mar. 21, 2024, Yield10 Bioscience announced that USDA-APHIS’s Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s Camelina…
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
On Dec. 13, 2023, In a study of historic scale, scientists at Gladstone Institutes announced that they had…
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
On May 3, 2023, Washington State University (WSU) made history in the United States (US) by becoming the…
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
On Mar. 1, 2022, Yield10 Bioscience announced that 2021 field test results showed that the trait C3020 tested…